Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LORIAN, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LORIAN, V.
(Chest. 1961;40:168-170.)
© 1961 American College of Chest Physicians

Experimental Intrabronchial Administration of Neomycin in Man and Animals

VICTOR LORIAN M.D.1

1 Department of Clinical Microbiology, The Hebrew University—Hadassah Medical School., Central Tuberculosis Laboratory, University of Brazil, Rio de Janeiro, Brazil.

Neomycin was administered to 36 patients, 220 guinea pigs and 28 rabbits either intrabronchially or parenterally and the pulmonary neomycin concentration was determined bacteriologically. Those who received the intrabronchial administration showed a pulmonary neomycin concentration after three hours 700 times higher than those which received parenteral injection. Concentration of 1360 mcg./ml. in the pulmonary tissue were found four hours after intrabronchial application. After 24 hours, the level was 40 mcg./ml. Therefore, intrabronchial administration of neomycin is advisable in neomycin-sensitive pulmonary infections.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1961 by the American College of Chest Physicians.